MBZUAI and Quris-AI have partnered to launch a Bio-AI center in Abu Dhabi during Abu Dhabi Sustainability Week. The center will focus on developing personalized medications tailored to the MENA region's diverse populations, leveraging Quris-AI's 'patient-on-a-chip' technology and MBZUAI's AI expertise. Quris-AI is establishing a UAE subsidiary, Quris-UAE, in Abu Dhabi as part of this collaboration. Why it matters: This initiative positions Abu Dhabi as a hub for Bio-AI research and personalized medicine, potentially accelerating drug development and reducing clinical trial failures in the region.
MBZUAI and the Department of Health – Abu Dhabi (DoH) have signed an agreement to collaborate on AI research across genomics, precision medicine, robotics, and AI-powered diagnostics. Signed on October 13, 2025, the MoU aims to drive breakthroughs in disease prevention, early detection, and therapeutics. The partnership seeks to translate AI research into tangible improvements in patient care within Abu Dhabi and beyond. Why it matters: This partnership signifies a major push to establish Abu Dhabi as a leader in biomedical research and AI-driven healthcare innovation.
MBZUAI and BioMap have signed an MoU to establish the first biocomputing innovation research lab in the Middle East, located on MBZUAI's campus. The collaboration will focus on applying AI protein generation to life science models, addressing needs in drug design, energy, and environmental protection. The lab will research de novo design of oil degradation enzymes and identify drug targets for aging-associated and rare diseases. Why it matters: This partnership signals a growing focus on applying AI to critical life science challenges in the region, potentially leading to breakthroughs in drug discovery and sustainable energy solutions.
MBZUAI has launched master’s and Ph.D. programs in computational biology, expanding its research into life sciences. This includes projects like AIDO (AI-Driven Digital Organism) and analysis of the Emirati Genome Program. The programs are part of MBZUAI’s School of Digital Public Health and aim to integrate computational biology with precision medicine. Why it matters: This initiative supports the UAE's vision for a knowledge-based economy and its ambition to become a global center for scientific and technological progress in biotechnology and healthcare.
A senior delegation from Weizmann Institute of Science visited MBZUAI in Abu Dhabi to discuss the MBZUAI-WIS Joint Program for Artificial Intelligence Research. The AI Program, announced in February, aims to promote collaborative initiatives in fundamental AI research and explore AI applications in healthcare and genomics. The program will focus on Machine Learning, Computer Vision, NLP, Computational Biology, and Neural Sciences, with plans for researcher appointments and resources. Why it matters: This partnership strengthens the AI ecosystem in the UAE and the region, particularly in fundamental research and key application areas.